Detalles de la búsqueda
1.
Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Breast Cancer Res Treat
; 205(2): 227-239, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38273214
2.
Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.
Acta Oncol
; 59(1): 75-81, 2020 Jan.
Artículo
en Inglés
| MEDLINE | ID: mdl-31583943
3.
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet Oncol
; 20(3): 339-351, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30795951
4.
Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
Ann Surg
; 269(6): 1163-1169, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-31082916
5.
Correction: Is the CTS5 a helpful decision-making tool in the extended adjuvant therapy setting?
Breast Cancer Res Treat
; 206(2): 441, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38704775
6.
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer (TURANDOT): primary endpoint results of a randomised, open-label, non-inferiority, phase 3 trial.
Lancet Oncol
; 17(9): 1230-9, 2016 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-27501767
7.
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Lancet
; 386(9992): 433-43, 2015 Aug 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-26040499
8.
Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
JAMA
; 316(18): 1888-1896, 2016 11 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27825007
9.
Outcome of chemotherapy extravasation in a large patient series using a standardised management protocol.
Support Care Cancer
; 23(6): 1741-8, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-25433440
10.
Bevacizumab plus paclitaxel versus bevacizumab plus capecitabine as first-line treatment for HER2-negative metastatic breast cancer: interim efficacy results of the randomised, open-label, non-inferiority, phase 3 TURANDOT trial.
Lancet Oncol
; 14(2): 125-33, 2013 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-23312888
11.
Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
N Engl J Med
; 360(7): 679-91, 2009 Feb 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-19213681
12.
Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Breast Care (Basel)
; 17(2): 137-145, 2022 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-35707180
13.
The cancer survival index-A prognostic score integrating psychosocial and biological factors in patients diagnosed with cancer or haematologic malignancies.
Cancer Med
; 11(18): 3387-3396, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35315594
14.
Assessing the impact of antiemetic guideline compliance on prevention of chemotherapy-induced nausea and vomiting: Results of the nausea/emesis registry in oncology (NERO).
Eur J Cancer
; 166: 126-133, 2022 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-35290913
15.
Single-agent pegylated liposomal doxorubicin (PLD) in the treatment of metastatic breast cancer: results of an Austrian observational trial.
BMC Cancer
; 11: 373, 2011 Aug 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-21864402
16.
Combination therapy of lapatinib and Capecitabine for ErbB2-positive metastatic or locally advanced breast cancer: results from the Lapatinib Expanded Access Program (LEAP) in Central and Eastern Europe.
Onkologie
; 34(5): 233-8, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21577028
17.
Sentinel node biopsy after primary chemotherapy in breast cancer: a note of caution from results of ABCSG-14.
Breast J
; 17(3): 230-8, 2011.
Artículo
en Inglés
| MEDLINE | ID: mdl-21450019
18.
Tissue distribution of epirubicin after severe extravasation in humans.
Cancer Chemother Pharmacol
; 88(2): 203-209, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-33907881
19.
Prognostic value of KRAS mutations in stage III colon cancer: post hoc analysis of the PETACC8 phase III trial dataset.
Ann Oncol
; 26(4): 822-825, 2015 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-25814651
20.
Factors influencing agreement of breast cancer luminal molecular subtype by Ki67 labeling index between core needle biopsy and surgical resection specimens.
Virchows Arch
; 477(4): 545-555, 2020 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-32383007